• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of October 9, 2024

    FDA

    Nivagen Pharmaceuticals Sells MedisourceRx Business Unit

    BUSINESSWIRE

    Nivagen Sells MedisourceRx To Hims & Hers

    CONTRACT PHARMA

    Persist AI And Nivagen Partner On AI-Driven Injectable Manufacturing

    PR NEWSWIRE

    Nivagen`s Generic Zinc Sulfate Receives Approval in US

    FDA

    Nivagen`s Generic Remifentanil Hydrochloride Receives Approval in US

    FDA

    Nivagen`s Generic Cysteine Hydrochloride Acetate Receives Approval in the U.S.

    FDA

    Nivagen`s Generic Calcium Gluconate Receives Approval in the U.S.

    FDA

    Nivagen’s Generics Glycopyrrolate Receives Approvals In US

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.